Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
Pfizer
Pfizer
University of Maryland, Baltimore
M.D. Anderson Cancer Center
Canadian Cancer Trials Group
Swiss Cancer Institute
R-Pharm
University of California, San Diego
Critical Outcome Technologies Inc.
Masonic Cancer Center, University of Minnesota
Memorial Sloan Kettering Cancer Center
Massachusetts General Hospital
Radiation Therapy Oncology Group
University Health Network, Toronto
Cancer Trials Ireland
Amgen
Clovis Oncology, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fox Chase Cancer Center
AstraZeneca
GlaxoSmithKline
M.D. Anderson Cancer Center
SWOG Cancer Research Network
Barbara Ann Karmanos Cancer Institute
Fox Chase Cancer Center
National Cancer Institute (NCI)